FDA Grants Accelerated Approval to Capmatinib for NSCLC

The FDA granted accelerated approval to capmatinib for adult patients with metastatic non-small cell lung cancer.

Source: CancerNetwork - May 6, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news